These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9870439)

  • 21. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.
    Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of tumour necrosis factor-alpha during haemodialysis. Influence of the membrane type.
    Chollet-Martin S; Stamatakis G; Bailly S; Mery JP; Gougerot-Pocidalo MA
    Clin Exp Immunol; 1991 Feb; 83(2):329-32. PubMed ID: 1993364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodialysis-associated induction of cytokines.
    Lonnemann G; Haubitz M; Schindler R
    Blood Purif; 1990; 8(4):214-22. PubMed ID: 2085429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination.
    Bigazzi R; Atti M; Baldari G
    Blood Purif; 1990; 8(4):190-8. PubMed ID: 2085427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of membrane characteristics on cytokine production by mononuclear cells in regular haemodialysis patients.
    Kino K; Akizawa T; Koshikawa S
    Nephrol Dial Transplant; 1995; 10 Suppl 3():29-33. PubMed ID: 7494611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel bio-assay increases the detection yield of microbiological impurity of dialysis fluid, in comparison to the LAL-test.
    Glorieux G; Schepers E; Schindler R; Lemke HD; Verbeke F; Dhondt A; Lameire N; Vanholder R
    Nephrol Dial Transplant; 2009 Feb; 24(2):548-54. PubMed ID: 18768583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic haemodialysis with bicarbonate dialysate. Technical and clinical aspects.
    Leunissen KM; Claessens PJ; Mooy JM; van Hooff JP; Shaldon S
    Blood Purif; 1990; 8(6):347-58. PubMed ID: 2093332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo intracellular cytokine production by leukocytes during haemodialysis.
    Rousseau Y; Haeffner-Cavaillon N; Poignet JL; Meyrier A; Carreno MP
    Cytokine; 2000 May; 12(5):506-17. PubMed ID: 10857769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin/cytokine profiles in haemodialysis and in continuous peritoneal dialysis.
    Jacobs P; Glorieux G; Vanholder R
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V41-45. PubMed ID: 15284359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of interleukin 1 receptor antagonist and interleukin 1 during haemodialysis with cellulose membranes.
    Frith SE; Hoenich NA; Redfern CP; Goodship TH
    Int J Artif Organs; 1994 Sep; 17(9):478-87. PubMed ID: 7890436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 receptors and receptor antagonist in haemodialysis.
    Donati D; Degiannis D; Mazzola E; Gastaldi L; Raskova J; Raska K; Camussi G
    Nephrol Dial Transplant; 1997 Jan; 12(1):111-8. PubMed ID: 9027784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine production and nutritional status in hemodialysis patients.
    King AJ; Kehayias JJ; Roubenoff R; Schmid CH; Pereira BJ
    Int J Artif Organs; 1998 Jan; 21(1):4-11. PubMed ID: 9554819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of haemodialysis and hepatitis c virus infection in spontaneous and induced cytokine production of patients with chronic renal disease.
    Martín J; de Sequera P; Quiroga JA; Rico M; Fernández M; Arocena C; Caramelo C; Carreño V
    Cytokine; 2000 Aug; 12(8):1248-52. PubMed ID: 10930306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
    Wright S; Steinwandel U; Ferrari P
    Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation between beta-2 microglobulin and IL-1 production in hemodialyzed patients.
    Carreno MP; Rousseau Y; Poignet JL; Jahns G; Cholley B; Kazatchkine MD; Haeffner-Cavaillon N
    Nephrol Dial Transplant; 1997 Nov; 12(11):2365-74. PubMed ID: 9394324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas aeruginosa contaminated dialysate.
    Jaber BL; Gonski JA; Cendoroglo M; Balakrishnan VS; Razeghi P; Dinarello CA; Pereira BJ
    Blood Purif; 1998; 16(4):210-9. PubMed ID: 9736790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of different glucose concentrations in haemodialysis solutions on metabolism and blood pressure stability in diabetic patients.
    Simic-Ogrizovic S; Backus G; Mayer A; Vienken J; Djukanovic L; Kleophas W
    Int J Artif Organs; 2001 Dec; 24(12):863-9. PubMed ID: 11831591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocyte activation in peripheral blood and dialyser eluates: phenotypic profile and cytokine release.
    Schouten WE; Grooteman MP; Schoorl M; van Houte AJ; Nubé MJ
    Nephron; 2002 Aug; 91(4):646-53. PubMed ID: 12138268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of contaminated dialysate in hemodialysis-associated cytokine production.
    Lonnemann G
    Contrib Nephrol; 1990; 86():121-7. PubMed ID: 2078948
    [No Abstract]   [Full Text] [Related]  

  • 40. Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study.
    Brunelli SM; Sibbel S; Do TP; Cooper K; Bradbury BD
    Am J Kidney Dis; 2015 Oct; 66(4):655-65. PubMed ID: 26015274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.